Bradley Merrill Thompson Quoted in “FDA Updates Food Categories in Rare Guidance with ‘Binding Effect'”FDA Week October 6, 2016
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in FDA Week, in “FDA Updates Food Categories in Rare Guidance with ‘Binding Effect,’” by David Lim.
Following is an excerpt:
Brad Thompson, a medical device attorney with Epstein Becker & Green whose advocacy resulted in the good guidance practices, said the nature of the guidance is limited, and not something that would appear on the medical device side.
"As you saw, it's pretty idiosyncratic, the bioterrorism act and the food act, whatever binding character it has comes from those authorities, and there aren't similar authorities on the medical devices side," Thompson said to IHP. "There's really nothing that can make a medical device guidance binding. I don't think the vast majority in the medical device realm would want a binding guidance."